Published Online
on August 2, 2007

A more recent version of this article appeared on September 1, 2007

This Article Full Text (PDF) All Versions of this Article: 38/9/2477    most recent STROKEAHA.106.479030v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coll, B. Articles by Masana, L. Search for Related Content PubMed PubMed Citation Articles by Coll, B. Articles by Masana, L. Related Collections Risk Factors Imaging Other diagnostic testing Doppler ultrasound, Transcranial Doppler etc. Genetics of cardiovascular disease

Submitted on December 1, 2006
Revised on February 11, 2007
Accepted on March 6, 2007

The Role of Immunity and Inflammation in the Progression of Atherosclerosis in Patients With HIV Infection

Blai Coll MD^*; Sandra Parra MD; Carlos Alonso-Villaverde MD; Gerard Aragonés; Manuel Montero MD; Jordi Camps PhD; Jorge Joven MD; and Lluis Masana MD

From the Centre de Recerca Biomédica (B.C., G.A., J.C., J.J.), Servei de Medicina Interna (B.C., S.P., C.A.-V., L.M.), and Servei de Radiología (M.M.), Hospital Universitari Sant Joan, Reus, Spain.

^* To whom correspondence should be addressed. E-mail: bcoll{at}grupsagessa.com.

Background and Purpose—The initial steps of atherosclerosis and the entry of HIV into the cell share similar biological mechanisms. Therefore, our hypothesis is that the progression of atherosclerosis in patients with HIV infection can be influenced by variations in genes implicated in both processes.

Methods and Results—The progression of atherosclerosis over a 2-year follow-up period was measured as the combined carotid and femoral intima media thickness (IMT) in 141 patients with HIV infection. The IMT (IMT_follow-up-IMT_baseline) values were used to segregate patients as minimal progressors or regressors (lowest IMT tertile), slow progressors (mid IMT tertile), and rapid progressors (highest IMT tertile). Mutations CCR-532, CCR-2 64I, MCP-1-2518G, SDF1-3'A, and CX3CR-1 (T280 mol/L and V249I) in the host DNA were determined. Mean age of the patients was 38.96 (SEM: 0.61) and 68.8% were male. The mean IMT was 0.045 mm (0.01) per year, which represented a significant progression (P<0.001) with respect to baseline values. Patients with minimal progression or regression had a significantly (P=0.01) higher CD4 cell count than slow progressors and rapid progressors. Multivariate analyses indicated that age and total cholesterol were positively associated with IMT progression. In contrast, the CD4 cell count, the SDF1-3'A, and the CX3CR-1 249 I mutated alleles were associated with lesser IMT progression.

Conclusion—The course of atherosclerosis in patients with HIV infection is influenced by polymorphisms in the SDF1 and CX3CR1 genes by metabolic variables and by the CD4 cell count. These data would be of help in assessing therapeutic needs of these patients.

Key words: atherosclerosis • chemokine polymorphisms • HIV • intima media thickness • nonconventional cardiovascular disease risk factors

This article has been cited by other articles:

				E Hulten, J Mitchell, J Scally, B Gibbs, and T C Villines HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies Heart, November 15, 2009; 95(22): 1826 - 1835. [Abstract] [Full Text] [PDF]

				L Calza, G Verucchi, D Pocaterra, M Pavoni, A Alfieri, A Cicognani, R Manfredi, C Serra, and F Chiodo Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection Int J STD AIDS, October 1, 2009; 20(10): 683 - 689. [Abstract] [Full Text] [PDF]

				M. Masia, E. Bernal, S. Padilla, N. Garcia, J. C. Escribano, E. Martinez, and F. Gutierrez A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk J. Antimicrob. Chemother., September 1, 2009; 64(3): 589 - 598. [Abstract] [Full Text] [PDF]

				H.-T. Tsai, Y.-T. Tee, Y.-H. Hsieh, H.-L. Chiou, C.-W. Lin, H.-C. Tsai, P.-H. Wang, and S.-F. Yang Elevated Plasma Stromal Cell-derived Factor 1 Protein and its Gene Polymorphism in Patients With Pelvic Inflammatory Disease Reproductive Sciences, June 1, 2009; 16(6): 610 - 617. [Abstract] [PDF]

				S. Debette, S. Bevan, J.-F. Dartigues, M. Sitzer, M. Lorenz, P. Ducimetiere, P. Amouyel, and H. S. Markus Fractalkine Receptor/Ligand Genetic Variants and Carotid Intima-Media Thickness Stroke, June 1, 2009; 40(6): 2212 - 2214. [Abstract] [Full Text] [PDF]

				B. Coll, C. Alonso-Villaverde, and L. Masana Influence of Inflammatory Variables on Intima-Media Thickness Stroke, January 1, 2008; 39(1): e16 - e16. [Full Text] [PDF]